FASLG and cancer: Similar results have been also been observed in other types of cancer cells such as the multidrug-resistant leukemia cells (HL60-R and K562-ADR) and Fas-ligand-resistant lymphoma cells (HUT78B1 and HUT78B3)16, 37.